Clinical Trials
Showing of 19 results
University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours
Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.
Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.
Cleveland Innovation District Partners Exceeding Many Targets Set by State and JobsOhio
25 examples of progress showcase the impact of successful collaboration.
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.
New Alzheimer's Disease Study Seeks Northeast Ohio Volunteers with Down Syndrome
As many as eight in 10 people with Down syndrome develop Alzheimer’s disease; new study needs volunteers to help identify causes and treatments
Clinical Trial Shows Injectable Weight Loss Drug Directly Reduces Abdominal Fat
Findings could potentially widen use for overweight adults who are high risk for heart disease.
New Technology Matching Patients Genomic Testing with Available Clinical Trials Nationwide Arrives at UH
Cleveland-based GenomOncology and UH Seidman Cancer Center enter into a market-leading partnership to increase clinical trial accrual rates.